Active, not recruiting
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
NCT03667820
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States